X

Vous n'êtes pas connecté

Articles similaires

Sorry! Image not available at this time

Oracle's AI Push: A Potential Catalyst for Q1 Earnings Growth?

zacks.com - 06/Sep 13:44

ORCL's fiscal first-quarter results are likely to reflect rapid adoption and progress in AI-based cloud services offering potential for future...

Sorry! Image not available at this time

FDA Approves Lilly's Ebglyss (lebrikizumab) for Atopic Dermatitis

drugs.com - 13/Sep 00:09

Ebglyss provides a new first-line biologic treatment for moderate-to-severe atopic dermatitis that is not well controlled with topicals Patients...

Sorry! Image not available at this time

FDA Approves Lilly's Ebglyss (lebrikizumab) for Atopic Dermatitis

drugs.com - 13/Sep 00:09

Ebglyss provides a new first-line biologic treatment for moderate-to-severe atopic dermatitis that is not well controlled with topicals Patients...

Sorry! Image not available at this time

Femasys Stock Rises After FDA Clearance for FemChec Diagnostic Device

zacks.com - 10/Sep 14:41

FEMY gains after FDA clearance for FemChec, a fallopian tube diagnostic tool designed for safe, in-office use, enhancing non-surgical birth control...